P17.93 THIRD LINE CHEMOTHERAPY IN HIGH GRADE GLIOMAS: THERE IS A BENEFIT?

BACKGROUND: Advances in surgical approaches, radiotherapy, and chemotherapy are contributing to incremental improvements in survival of the patients with High Grade Gliomas (HGG) but few options exist for the management of recurrent or resistant disease. Long survivors are often treated with more li...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Villani, V., Fabi, A., Terrenato, I., Telera, S., Marucci, L., Carosi, M., Vidiri, A., Carapella, C.M., Pace, A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185797/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.422
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars